New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic dermatitis.
DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
What were the hot medical aesthetic trends of 2019 and what’s in the pipeline for 2020? Joel L. Cohen, MD weighs in.
Joel L. Cohen, MD, FAAD
Ask an Expert
In the second video in a series, Steven Cohen, MD talks about standard and new treatments for hidradenitis suppurativa. He talks to host Adam...
Steven Cohen, MD; and Adam Friedman, MD, FAAD
John E. Harris, MD, PhD explains why his frequent travel might leave his staff feeling a bit annoyed at times!
John E. Harris, MD, PhD
DermWire TV: Merz Reorganizes; Amzeeq Approved; Restoration Merges with Venus Concept
Do you struggle to communicate research studies, statistics, aftercare instructions, and other complex ideas to your patients? This Ekwa...
Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these...
Jill Waibel, MD
truSculpt flex is a muscle sculpting/muscle building device that offers personalized treatments based on patient fitness level, shape, and goals. Only...
Kathleen J. Hectorne, MD shares a memory about a trip to The Boundary Waters Canoe Area Wilderness in Minnesota.
Kathleen J. Hectorne, MD